TAKEDA PHARMACEUTICAL CO LTD — SEC Form 4 filings

SEC reporting owner CIK 1395064. 3 Form 4 filings on record with FilingPulse; latest filed 2025-12-09.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-01-25 to 2025-12-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Phathom Pharmaceuticals, Inc. (PHAT)10% owner11 leg · 3,703,703 sh · $29,999,994
Ovid Therapeutics Inc. (OVID)10% owner12
HilleVax, Inc. (HLVX)10% owner11

Form 4 filings — TAKEDA PHARMACEUTICAL CO LTD

FiledFormIssuerReported transactionsSource
2025-12-094Ovid Therapeutics Inc. (OVID)
jointly with Takeda Pharmaceuticals U.S.A., Inc.
Conversion (C): 1,250,000 @ $0 · Conversion (C): 1,250 (derivative) @ $0EDGAR
2025-09-194HilleVax, Inc. (HLVX)
jointly with Takeda Vaccines, Inc.
Code (U): 6,724,000 @ $1.95EDGAR
2024-01-254Phathom Pharmaceuticals, Inc. (PHAT)Sale (S): 3,703,703 @ $8.10EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1395064 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →